← Leaderboards

George Robert Stark

Cleveland Clinic Foundation

Google Scholar ↗PubMed ↗ORCID ↗

$19,236,463

Attributed

$19,426,069

Total exposure

16

Grants

13

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.3M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$62,563,061 · 18

By mechanism

P01$54,714,582 · 13

R01$7,464,267 · 3

R21$379,212 · 1

R13$5,000 · 1

Top collaborators

Xiaoxia Li3 shared
Mark W Jackson2 shared

Most similar at Cleveland Clinic Foundation

Same institution · by research overlap

Xiaoxia Li$26,894,441
Bryan R. G. Williams$8,873,982

Others in their field

Top investigators on “Cytokine”

Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
Marianne Ward · Duke University$34,872,957
Joren C Madsen · Massachusetts General Hospital$33,058,731
Barton F Haynes · Duke University$29,068,807

Research focus

CytokineSignal TransductionInflammationMalignant NeoplasmsCellsResponsePhosphorylationProgramsAffectGene ExpressionTranscription FactorPhenotypeGenetic TranscriptionComplexPathway InteractionsInflammatoryProteinsGenesTumorigenesisMediatingTumorStat3 GeneInterferonsCell Type

Grant awards (90)

Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment$1,916,095

P01 · FY2025 · CA · contact PI

Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy$483,558

P01 · FY2025 · CA · contact PI

Administrative Core$118,741

P01 · FY2025 · CA · contact PI

Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment$1,820,290

P01 · FY2024 · CA · contact PI

Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy$459,381

P01 · FY2024 · CA · contact PI

Administrative Core$112,803

P01 · FY2024 · CA · contact PI

Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment$1,877,772

P01 · FY2023 · CA · contact PI

Two novel threonine phosphorylations of STAT2 impact inflammatory responses to bacterial infection.$562,646

R01 · FY2023 · AI · contact PI

Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy$475,893

P01 · FY2023 · CA · contact PI

Administrative Core$111,076

P01 · FY2023 · CA · contact PI

Molecular Dissection of Cytokine Crosstalk in the Tumor Microenvironment$1,916,095

P01 · FY2022 · CA · contact PI

Two novel threonine phosphorylations of STAT2 impact inflammatory responses to bacterial infection.$562,646

R01 · FY2022 · AI · contact PI

Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy$483,558

P01 · FY2022 · CA · contact PI

Administrative Core$118,741

P01 · FY2022 · CA · contact PI

Two novel threonine phosphorylations of STAT2 impact inflammatory responses to bacterial infection.$562,646

R01 · FY2021 · AI · contact PI

Integrated EGFR function in cytokine-driven inflammation and cancer$1,805,475

P01 · FY2020 · CA · contact PI

Two novel threonine phosphorylations of STAT2 impact inflammatory responses to bacterial infection.$562,646

R01 · FY2020 · AI · contact PI

How does EGFR facilitate the constitutive activation of STAT3 in tumors?$429,633

P01 · FY2020 · CA · contact PI

Proteomics Core$274,264

P01 · FY2020 · CA · contact PI

Administrative Core$234,999

P01 · FY2020 · CA · contact PI

Integrated EGFR function in cytokine-driven inflammation and cancer$1,751,310

P01 · FY2019 · CA · contact PI

How does EGFR facilitate the constitutive activation of STAT3 in tumors?$418,801

P01 · FY2019 · CA · contact PI

Proteomics Core$263,430

P01 · FY2019 · CA · contact PI

Administrative Core$224,165

P01 · FY2019 · CA · contact PI

Integrated EGFR function in cytokine-driven inflammation and cancer$1,805,475

P01 · FY2018 · CA · contact PI

How does EGFR facilitate the constitutive activation of STAT3 in tumors?$429,633

P01 · FY2018 · CA · contact PI

Proteomics Core$274,265

P01 · FY2018 · CA · contact PI

Administrative Core$234,999

P01 · FY2018 · CA · contact PI

Integrated EGFR function in cytokine-driven inflammation and cancer$1,805,475

P01 · FY2017 · CA · contact PI

How does EGFR facilitate the constitutive activation of STAT3 in tumors?$234,589

P01 · FY2017 · CA · contact PI

Interferon-beta inhibits the expansion of cancer stem-cells$206,843

R21 · FY2017 · CA

Proteomics Core$94,758

P01 · FY2017 · CA · contact PI

Administrative Core$59,422

P01 · FY2017 · CA · contact PI

Integrated EGFR function in cytokine-driven inflammation and cancer$1,805,475

P01 · FY2016 · CA · contact PI

How does EGFR facilitate the constitutive activation of STAT3 in tumors?$504,935

P01 · FY2016 · CA · contact PI

Proteomics Core$178,861

P01 · FY2016 · CA · contact PI

Interferon-beta inhibits the expansion of cancer stem-cells$172,369

R21 · FY2016 · CA

Administrative Core$96,462

P01 · FY2016 · CA · contact PI

Signaling in Inflammation, Stress, and Tumorigenesis$1,791,470

P01 · FY2015 · CA · contact PI

Mechanisms and functions of lysine methylation of promoter-bound NFkB and STAT3$458,113

P01 · FY2015 · CA · contact PI

Administrative Core$89,944

P01 · FY2015 · CA · contact PI

Signaling in Inflammation, Stress, and Tumorigenesis$1,741,359

P01 · FY2014 · CA · contact PI

Mechanisms and functions of lysine methylation of promoter-bound NFkB and STAT3$453,863

P01 · FY2014 · CA · contact PI

Administrative Core$84,302

P01 · FY2014 · CA · contact PI

Signaling in Inflammation, Stress, and Tumorigenesis$1,690,953

P01 · FY2013 · CA · contact PI

Mechanisms and functions of lysine methylation of promoter-bound NFkB and STAT3$355,983

P01 · FY2013 · CA · contact PI

Administrative Core$189,046

P01 · FY2013 · CA · contact PI

Signaling in Inflammation, Stress, and Tumorigenesis$1,802,633

P01 · FY2012 · CA · contact PI

Mechanisms and functions of lysine methylation of promoter-bound NFkB and STAT3$512,236

P01 · FY2012 · CA · contact PI

Activators and repressors of NFkappaB and IRF3/7 in innate immunity$264,740

R01 · FY2012 · CA · contact PI

Administrative Core$103,229

P01 · FY2012 · CA · contact PI

Signaling in Inflammation, Stress, and Tumorigenesis$1,806,455

P01 · FY2011 · CA · contact PI

Mechanisms and functions of lysine methylation of promoter-bound NFkB and STAT3$514,166

P01 · FY2011 · CA · contact PI

Activators and repressors of NFkappaB and IRF3/7 in innate immunity$264,740

R01 · FY2011 · CA · contact PI

Administrative Core$103,618

P01 · FY2011 · CA · contact PI

Activators and repressors of NFkappaB and IRF3/7 in innate immunity$272,927

R01 · FY2010 · CA · contact PI

IFNs and Cytokines: Signaling and Action$1,995,246

P01 · FY2009 · CA · contact PI

Novel Essential Pathways For IFN-Dependent Gene Expression$470,952

P01 · FY2009 · CA · contact PI

Activators and repressors of NFkappaB and IRF3/7 in innate immunity$272,927

R01 · FY2009 · CA · contact PI

IFNs and Cytokines: Signaling and Action$1,949,778

P01 · FY2008 · CA · contact PI

Novel Essential Pathways For IFN-Dependent Gene Expression$459,413

P01 · FY2008 · CA · contact PI

Activators and repressors of NFkappaB and IRF3/7 in innate immunity$272,927

R01 · FY2008 · CA · contact PI

IFNs and Cytokines: Signaling and Action$1,941,139

P01 · FY2007 · CA · contact PI

Novel Essential Pathways For IFN-Dependent Gene Expression$457,098

P01 · FY2007 · CA · contact PI

Negative Regulators of NFkappaB$258,227

R01 · FY2007 · CA · contact PI

IFNs and Cytokines: Signaling and Action$1,951,862

P01 · FY2006 · CA · contact PI

NOVEL REGULATORS OF P53 ACCUMULATION AND FUNCTION$373,511

R01 · FY2006 · GM · contact PI

Novel Essential Pathways For IFN-Dependent Gene Expression$298,493

P01 · FY2006 · CA · contact PI

Negative Regulators of NFkappaB$265,940

R01 · FY2006 · CA · contact PI

IFNs and Cytokines: Signaling and Action$1,943,280

P01 · FY2005 · CA

NOVEL REGULATORS OF P53 ACCUMULATION AND FUNCTION$382,500

R01 · FY2005 · GM

Novel Essential Pathways For IFN-Dependent Gene Expression$290,047

P01 · FY2005 · CA

Negative Regulators of NFkappaB$272,340

R01 · FY2005 · CA

NOVEL REGULATORS OF P53 ACCUMULATION AND FUNCTION$382,500

R01 · FY2004 · GM

Negative Regulators of NFkappaB$272,340

R01 · FY2004 · CA

IFNS AND CYTOKINES--SIGNALING AND ACTION$99,999

P01 · FY2004 · CA

IFNS AND CYTOKINES--SIGNALING AND ACTION$2,043,679

P01 · FY2003 · CA

NOVEL REGULATORS OF P53 ACCUMULATION AND FUNCTION$313,009

R01 · FY2003 · GM

Negative Regulators of NFkappaB$265,220

R01 · FY2003 · CA

NOVEL REGULATORS OF P53 ACCUMULATION AND FUNCTION$69,491

R01 · FY2003 · GM

IFNS AND CYTOKINES--SIGNALING AND ACTION$1,995,499

P01 · FY2002 · CA

P53 MODIFICATION AND NOVEL BIOLOGICAL FUNCTIONS$346,698

R01 · FY2002 · GM

GENETIC ANALYSIS OF MAMMALIAN SIGNALING PATHWAYS$91,598

P01 · FY2002 · CA

Conference on JAKs &STATs: Activation &Biologic Impact$5,000

R13 · FY2002 · CA

IFNS AND CYTOKINES--SIGNALING AND ACTION$1,963,207

P01 · FY2001 · CA

P53 MODIFICATION AND NOVEL BIOLOGICAL FUNCTIONS$336,684

R01 · FY2001 · GM

GENETIC ANALYSIS OF MAMMALIAN SIGNALING PATHWAYS$91,598

P01 · FY2001 · CA

IFNS AND CYTOKINES--SIGNALING AND ACTION$1,916,971

P01 · FY2000 · CA

P53 MODIFICATION AND NOVEL BIOLOGICAL FUNCTIONS$326,962

R01 · FY2000 · GM

GENETIC ANALYSIS OF MAMMALIAN SIGNALING PATHWAYS$236,924

P01 · FY2000 · CA